Q1
Lundbeck moves ahead in Q1
May 3, 2013Sales and Marketing Lexapro, Lundbeck, Otsuka, Q1
Lundbeck’s sales and profit increase in the first three months of 2013 was due largely to one-off payments it received, …
‘Solid’ start for Novartis
April 30, 2013Sales and Marketing Novartis, Q1, sales
Novartis’ sales of pharma products were unchanged in the first quarter of 2013 at $7.9 billion, with pricing flat, the …
Zyprexa decline hits Lilly
April 26, 2013Sales and Marketing Q1, lilly, zyprexa
Loss of exclusivity on Lilly’s blockbuster antipsychotic Zyprexa in 2011 continued to hit the company hard in the first quarter …
Cancer drugs boost Roche
April 12, 2013Sales and Marketing Cancer, Q1, Roche
Roche saw overall sales rise 6% year-on-year in the first three months of this year on the back of a …
DSM sees green shoots for pharma unit in Q1
May 8, 2012Business Services, Manufacturing and Production, Sales and Marketing DSM, Kensey Nash, NSCLC, Q1, Sinochem
DSM said its pharmaceutical business unit posted ‘weak’ financials in the first quarter of 2012, although revenues rose and there …
Brennan bows to pressure and quits AstraZeneca
April 26, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, David Brennan, Q1, pharma
AstraZeneca’s chief executive David Brennan is to step down from his post following mounting dissatisfaction with his leadership. Brennan, who …
Novartis Q1 earnings slide down
April 26, 2012Sales and Marketing Novartis, Q1, Sandoz, generics, gilenya
Generic competition and problems at a US plant were among the reasons why Novartis’ sales and profit dipped in the …
Latest content
FibroFind appoints Lee Borthwick as CEO
